{
    "title": "114_hr5659",
    "content": "The Act is titled the \"Expanding Seniors Receiving Dialysis Choice Act of 2016\" or the \"ESRD Choice Act of 2016.\" It aims to expand Medicare Advantage coverage for individuals with end-stage renal disease (ESRD). The Act, titled the \"Expanding Seniors Receiving Dialysis Choice Act of 2016\" or the \"ESRD Choice Act of 2016,\" aims to expand Medicare Advantage coverage for individuals with end-stage renal disease (ESRD). Section 1851(a)(3) of the Social Security Act is amended to expand MA eligibility. The Medicare Advantage organization is being amended to exclude costs for kidney acquisitions from the MA benchmark. The Medicare Advantage organization is being amended to exclude costs for kidney acquisitions from the MA benchmark starting in 2019. This adjustment will remove the standardized costs for organ acquisitions for kidney transplants from the capitation rates. The Medicare Advantage organization is amending the capitation rates to exclude costs for kidney acquisitions starting in 2019. This adjustment will remove standardized costs for organ acquisitions for kidney transplants. The Social Security Act is amended to include coverage for organ acquisitions for kidney transplants under Medicare Advantage. Medicare Advantage organizations will adjust capitation rates to exclude costs for kidney acquisitions starting in 2019. The Centers for Medicare & Medicaid Services should adjust risk adjustment for Medicare Advantage to accommodate individuals with end-stage renal disease. Additionally, there will be expanded education for Medicare Advantage enrollees with end-stage renal disease. A report on the impact of these changes on traditional Medicare spending is due by April 1, 2022. The amendments made by this section will apply to plan years starting on or after January 1, 2020, focusing on Medicare fee-for-service programs under parts A and B of the Social Security Act, as well as parts C and D. The report will assess risk adjustment payment methodologies for individuals with end-stage renal disease and provide recommendations. The House of Representatives passed the bill on September 21, 2016."
}